Literature DB >> 15866507

pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective.

Roland A Cooper1, Carmony L Hartwig, Michael T Ferdig.   

Abstract

Genetic, physiological and pharmacological studies are gradually revealing the molecular basis of chloroquine resistance (CQR) in the malaria parasite, Plasmodium falciparum. Recent highlights include the discovery of a key gene associated with resistance, pfcrt (Plasmodium falciparum chloroquine resistance transporter; PfCRT), encoding a novel transporter, and the characterization of global selective sweeps of haplotypes containing a K76T amino acid change within this protein. Little is known about the cellular mechanism by which resistant parasites escape the effects of chloroquine (CQ), one of the most promising drugs ever deployed, due in part to an unresolved mechanism of action. The worldwide spread of CQR argues that investigations into these mechanisms are of little value. We propose, to the contrary, that the reconstruction of the evolutionary and molecular events underlying CQR is important at many levels, including: (i) its potential to assist in the development of rational approaches to thwart future drug resistances; (ii) the stimulation of the use of CQ-like compounds in drug combinations for new therapeutic approaches; and (iii) the consideration of how the CQ-selected genome will function as the context in which current and future drugs will act, particularly in light of the many reports of multidrug resistance. The purpose of this review is to highlight, discuss and in some cases challenge the interpretations of recent findings on CQR. We consider the natural function of the PfCRT protein, the role of multiple genes and "genetic background" in the CQR mechanism, and the evolution of CQR in parasite populations. Genetic transformation techniques are improving in P. falciparum and continue to provide important insight into CQR. Here, we also discuss more subtle, yet important pharmacological approaches that may have been overlooked in a traditional "gene for drug resistance" way of thinking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866507     DOI: 10.1016/j.actatropica.2005.04.004

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  47 in total

Review 1.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

2.  Incorporation of an intramolecular hydrogen-bonding motif in the side chain of 4-aminoquinolines enhances activity against drug-resistant P. falciparum.

Authors:  Peter B Madrid; Ally P Liou; Joseph L DeRisi; R Kiplin Guy
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

3.  Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.

Authors:  Rajeev K Mehlotra; Gabriel Mattera; Moses J Bockarie; Jason D Maguire; J Kevin Baird; Yagya D Sharma; Michael Alifrangis; Grant Dorsey; Philip J Rosenthal; David J Fryauff; James W Kazura; Mark Stoneking; Peter A Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

Review 4.  Drug resistance and genetic mapping in Plasmodium falciparum.

Authors:  Karen Hayton; Xin-Zhuan Su
Journal:  Curr Genet       Date:  2008-09-18       Impact factor: 3.886

5.  Functionalized Naphthalimide-4-aminoquinoline Conjugates as Promising Antiplasmodials, with Mechanistic Insights.

Authors:  Jenny Legac; Adebayo A Adeniyi; Prishani Kisten; Philip J Rosenthal; Parvesh Singh; Vipan Kumar
Journal:  ACS Med Chem Lett       Date:  2020-01-08       Impact factor: 4.345

Review 6.  Drug-resistant malaria - an insight.

Authors:  John E Hyde
Journal:  FEBS J       Date:  2007-09       Impact factor: 5.542

7.  Analysis of gene mutations involved in chloroquine resistance in Plasmodium falciparum parasites isolated from patients in the southwest of Saudi Arabia.

Authors:  Saad M Bin Dajem; Ahmed Al-Qahtani
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

8.  Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.

Authors:  Bianca E Gama; Guilhermina A L Pereira-Carvalho; Florbela J I Lutucuta Kosi; Natália K Almeida de Oliveira; Filomeno Fortes; Philip J Rosenthal; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2010-06-18       Impact factor: 2.979

9.  Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum.

Authors:  Stephanie G Valderramos; Juan-Carlos Valderramos; Lise Musset; Lisa A Purcell; Odile Mercereau-Puijalon; Eric Legrand; David A Fidock
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

10.  Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.

Authors:  Jutta Marfurt; Thomas A Smith; Ian M Hastings; Ivo Müller; Albert Sie; Olive Oa; Moses Baisor; John C Reeder; Hans-Peter Beck; Blaise Genton
Journal:  Malar J       Date:  2010-01-07       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.